NNECOS Research Funding Grants

Student-Led Research Grants Also Available!



Applications due June 1st and December 15th

Since the program’s inception in 2008, the NNECOS Research Funding Program has awarded more than $140,000 to worthy projects of value to the Northern New England region.

Congratulations to the 2017 NNECOS Research Grant Recipients

NNECOS awarded a total of $45,694 in research grants to 2017 applicants

Cycle 2


  

  • The Efficacy of a Pharmacist‐led Smoking Cessation Intervention for Oncology Patients, Antoine Harb, MD, EMMC Cancer Care, Brewer, ME
  • DNA repair landscape of discordant sibling pairs from hereditary breast cancer families, Kara Landry, MD, Larner College of Medicine, University of Vermont
  • Assessing the Utility of Predictive Early Chimerism Analysis Following Haploidentical Stem Cell
    Transplant
    , Raphael Lizcano, MD, Dartmouth-Hitchcock/White River Junction, VA

Cycle 1


  • Pilot Study involving Active Surveillance with CT Imaging and Liquid Biopsies for Inoperable Stage IA Lung Cancer in the Elderly, Christopher Anker, MD, University of Vermont Medical Center
  • Use of a toxicity assessment questionnaire to evaluate clinical significance of the statin paclitaxel drug interaction, Michael Pelchat, RPh, NH Oncology-Hematology


Call for Proposals

The Northern New England Clinical Oncology Society is seeking research funding proposals for investigative projects of value to the entire Northern New England community of cancer care providers. The society seeks to award one or more research grants to worthy proposals, up to a total of $20,000. Eligible candidates will be a current NNECOS member in good standing. Projects should be in alignment with the society’s mission to assure access to high quality oncology care in our region. Preference will be given to projects promoting collaboration amongst NNECOS institutions (academic and community). Fellows and others are strongly encouraged to apply. 

Budget
Please note NNECOS is unable to fund indirect costs or investigator salaries as part of the grant budget. Funds for services of collaborating facility employees required in the operations of a project (i.e. research coordinator, statistician, etc.) will be considered, but should not exceed national averages for their role.

Awardees will be notified in approximately 30 days, be required to submit progress reports to NNECOS, and may be asked to present a final report of the research to the NNECOS annual meeting.

APPLICATION DEADLINE
! Completed applications must be received through online submission  no later than 11:00 pm on June 1, 2018.


Congratulations to 2011 NNECOS Research Grant recipient, Ivette Emery, PhD on publication of your study results in the Journal of Neuro-oncology!  https://link.springer.com/article/10.1007/s11060-017-2422-z


Past Projects Funded Include:

  • Clinical Trial Barrier Study
    • Assessment of perceived cost to the patient and other barriers to clinical trial participation. Weckstein DJ, Thomas CA, Emery IF, Shea BF, Fleury A, White ME, Chase E, Robinson C, Frazier S, Pilar C. J Oncol Pract. 2011 Sep;7(5):33

  • Exercise for Individuals with Stage IV Cancer
    • Litterini A, Cavanaugh J, Fieler V, Lee JQ.  Differential Effects of Cardiovascular and Resistance Exercise on Functional Mobility in Individuals with Advanced Cancer: A Randomized Trial. Arch Phys Med Rehabil. 2013;94:2329-35.

    • Litterini, A and Lee, J. “Exercise for Individuals with Metastatic Cancer.” APTA 2013 Combined Sections Meeting, Oncology Section Platform Presentation, San Diego, CA, 2013.

    • Litterini, A., and Fieler, V. “Differential Effects of Cardiovascular and Resistance Exercise on Functional Mobility in Individuals with Advanced Cancer: A Randomized Trial.” Poster Presentation, 2015 New England Cancer Survivorship Research Symposium, Harvard Medical School/ Dana-Farber Cancer Institute in Boston, MA, on April 2, 2015. Available [on-line]: http://dune.une.edu/pt_facpost/4

  • Head and neck cancer trial involving response to neoadjuvant chemotherapy
  • Inhibition of stem cell pathways in a patient-derived GBM tumor model system. Congratulations on publication in Journal of Neuro-oncology! 
  • Coagulation activation in brain neoplasms
  • DNA repair landscape in individuals with increased risk of breast cancer
  • Social Media Usage within the Cancer Community of Northern New England
  • Thrombin Generation as a Predictive Biomarker for Venous thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Chemotherapy
  • Synergistic targeting of CLL cells with DNA repair and B cell receptor inhibitors - view the poster
  • Pilot study of the role of MDSCs and VISTA in immunology of chronic graft-versus-host disease following reduced intensity allogeneic bone marrow transplantation
  • Pilot Study involving Active Surveillance with CT Imaging and Liquid Biopsies for Inoperable Stage IA Lung Cancer in the Elderly
  • Use of a toxicity assessment questionnaire to evaluate clinical significance of the statin paclitaxel drug interaction
  • The Efficacy of a Pharmacist‐led Smoking Cessation Intervention for Oncology Patients, Antoine Harb, MD
  • DNA repair landscape of discordant sibling pairs from hereditary breast cancer families
  • Assessing the Utility of Predictive Early Chimerism Analysis Following Haploidentical Stem Cell
    Transplant



Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software